X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Unichem Lab with AANJANEYA LIFECARE - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

UNICHEM LAB vs DR. DATSONS LABS - Comparison Results

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    UNICHEM LAB DR. DATSONS LABS UNICHEM LAB/
DR. DATSONS LABS
 
P/E (TTM) x -66.6 -10.9 - View Chart
P/BV x 0.7 0.2 459.0% View Chart
Dividend Yield % 2.3 0.0 -  

Financials

 UNICHEM LAB   DR. DATSONS LABS
EQUITY SHARE DATA
    UNICHEM LAB
Mar-18
DR. DATSONS LABS
Mar-14
UNICHEM LAB/
DR. DATSONS LABS
5-Yr Chart
Click to enlarge
High Rs382126 304.1%   
Low Rs23431 757.6%   
Sales per share (Unadj.) Rs116.3133.0 87.4%  
Earnings per share (Unadj.) Rs-18.90.2 -12,480.1%  
Cash flow per share (Unadj.) Rs-11.76.6 -177.7%  
Dividends per share (Unadj.) Rs5.000-  
Dividend yield (eoy) %1.60-  
Book value per share (Unadj.) Rs381.0128.8 295.8%  
Shares outstanding (eoy) m70.3431.66 222.2%   
Bonus/Rights/Conversions BBFCCB-  
Price / Sales ratio x2.60.6 450.2%   
Avg P/E ratio x-16.3516.1 -3.2%  
P/CF ratio (eoy) x-26.211.8 -221.6%  
Price / Book Value ratio x0.80.6 133.1%  
Dividend payout %-26.40-   
Avg Mkt Cap Rs m21,6682,477 874.6%   
No. of employees `0002.3NA-   
Total wages/salary Rs m2,00656 3,582.9%   
Avg. sales/employee Rs Th3,587.8NM-  
Avg. wages/employee Rs Th880.0NM-  
Avg. net profit/employee Rs Th-583.7NM-  
INCOME DATA
Net Sales Rs m8,1804,211 194.3%  
Other income Rs m61079 775.2%   
Total revenues Rs m8,7904,289 204.9%   
Gross profit Rs m-1,320569 -232.2%  
Depreciation Rs m505204 247.1%   
Interest Rs m80430 18.6%   
Profit before tax Rs m-1,29513 -10,199.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m-2-2 122.2%   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m336 547.9%   
Profit after tax Rs m-1,3315 -27,727.5%  
Gross profit margin %-16.113.5 -119.5%  
Effective tax rate %-2.648.0 -5.4%   
Net profit margin %-16.30.1 -14,272.0%  
BALANCE SHEET DATA
Current assets Rs m23,3186,852 340.3%   
Current liabilities Rs m4,6356,711 69.1%   
Net working cap to sales %228.43.3 6,820.1%  
Current ratio x5.01.0 492.7%  
Inventory Days Days122161 75.7%  
Debtors Days Days121318 38.1%  
Net fixed assets Rs m8,1633,673 222.2%   
Share capital Rs m141317 44.4%   
"Free" reserves Rs m26,6603,761 708.9%   
Net worth Rs m26,8014,078 657.3%   
Long term debt Rs m31,671 0.2%   
Total assets Rs m31,89012,633 252.4%  
Interest coverage x-15.21.0 -1,473.6%   
Debt to equity ratio x00.4 0.0%  
Sales to assets ratio x0.30.3 77.0%   
Return on assets %-3.93.4 -113.9%  
Return on equity %-5.00.1 -4,218.5%  
Return on capital %-4.57.7 -59.2%  
Exports to sales %022.9 0.0%   
Imports to sales %014.3 0.0%   
Exports (fob) Rs mNA964 0.0%   
Imports (cif) Rs mNA602 0.0%   
Fx inflow Rs m4,356964 451.9%   
Fx outflow Rs m0607 0.0%   
Net fx Rs m4,356357 1,220.6%   
CASH FLOW
From Operations Rs m-1,1231,345 -83.5%  
From Investments Rs m16,487-2,256 -730.9%  
From Financial Activity Rs m-8,811-1,200 734.4%  
Net Cashflow Rs m6,552-2,111 -310.4%  

Share Holding

Indian Promoters % 50.1 4.5 1,106.0%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 15.1 0.0 -  
FIIs % 3.0 1.4 222.2%  
ADR/GDR % 0.0 0.0 -  
Free float % 31.7 94.1 33.7%  
Shareholders   20,176 20,807 97.0%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare UNICHEM LAB With:   SUVEN LIFE  SUN PHARMA  PIRAMAL ENTERPRISES  FDC LTD.  SHASUN PHARMA  

Compare UNICHEM LAB With:   ACTAVIS (US)  MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 207 Points Higher; Healthcare Stocks Witness Buying(Closing)

Indian share markets continued to trade in the green during the closing hours of the trading session and ended the day on a positive note.

Related Views on News

UNICHEM LAB Announces Quarterly Results (1QFY19); Net Profit Down 1479.6% (Quarterly Result Update)

Aug 3, 2018 | Updated on Aug 3, 2018

For the quarter ended June 2018, UNICHEM LAB has posted a net profit of Rs 207 m (down 1479.6% YoY). Sales on the other hand came in at Rs 2 bn (down 35.9% YoY). Read on for a complete analysis of UNICHEM LAB's quarterly results.

UNICHEM LAB Announces Quarterly Results (4QFY18); Net Profit Down 91.1% (Quarterly Result Update)

Jun 14, 2018 | Updated on Jun 14, 2018

For the quarter ended March 2018, UNICHEM LAB has posted a net profit of Rs 28 m (down 91.1% YoY). Sales on the other hand came in at Rs 2 bn (down 40.4% YoY). Read on for a complete analysis of UNICHEM LAB's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

More Views on News

Most Popular

How to Make Big Profits by Following India's Best Investors(The 5 Minute Wrapup)

Aug 3, 2018

In a time when stocks recommended by so-called 'gurus of the market' are crashing, let Kunal Thanvi guide you to the best gurus...and their best stocks.

The Biggest Mistake You Can Make in this Market (and 3 Stocks to Buy Now!)(Profit Hunter)

Aug 3, 2018

This price pattern can help you identify stocks on the verge of a turnaround.

Does This Indicator Tell Us the Sensex is Headed for a Correction?(Vivek Kaul's Diary)

Aug 3, 2018

To what extent have foreign flows influenced Indian stock markets? How do we see it panning out now?

Is Franklin India Smaller Companies Fund Worth Your Money(Outside View)

Aug 2, 2018

Although positioned as a small cap fund, Franklin India Smaller Companies Fund has been investing a significant portion of its assets in mid-caps along with a nominal exposure to large caps.

Why HDFC Equity Fund Disappointed Its Investors(Outside View)

Aug 9, 2018

Though popular, HDFC Equity Fund is not among the best performers anymore. Here is the reason behind its underperformance that has left investors disappointed.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

UNICHEM LAB SHARE PRICE


Aug 14, 2018 (Close)

TRACK UNICHEM LAB

  • Track your investment in UNICHEM LAB with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

UNICHEM LAB - ELDER PHARMA COMPARISON

COMPARE UNICHEM LAB WITH

MARKET STATS